Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and use for treating subjects suffering from atypical hemolytic syndrome

摘要

The present invention relates to therapeutic methods of using stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, and kits comprising the formulations for treating subjects suffering from atypical hemolytic uremic syndrome (aHUS).